APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Allylamines Antifungal Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Allylamines Antifungal Drugs Market Analysis and Forecast 2026-2032

Report ID 173962150223 December 2025205 pages

Choose your research edition.

Industry ResearchAllylamines Antifungal Drugs Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal Allylamines Antifungal Drugs Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Allylamines Antifungal Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Allylamines Antifungal Drugs Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Allylamines Antifungal Drugs Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Allylamines Antifungal Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Allylamines Antifungal Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Allylamines Antifungal Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Allylamines Antifungal Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Allylamines Antifungal Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Allylamines Antifungal Drugs include Chongqing Huapont Pharmaceutical, Yangtze River Pharmaceutical Group, Xiuzheng Pharmaceutical Group, Tongyao Pharmaceutical Group, Teva, Shandong Chenxin Pharmaceutical, Sandoz, Qilu Pharmaceutical and Novartis, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Allylamines Antifungal Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Allylamines Antifungal Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Allylamines Antifungal Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Allylamines Antifungal Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Allylamines Antifungal Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Allylamines Antifungal Drugs sales, projected growth trends, production technology, application and end-user industry.

Allylamines Antifungal Drugs Segment by Company

Chongqing Huapont Pharmaceutical

Yangtze River Pharmaceutical Group

Xiuzheng Pharmaceutical Group

Tongyao Pharmaceutical Group

Teva

Shandong Chenxin Pharmaceutical

Sandoz

Qilu Pharmaceutical

Novartis

Nanjing Chenggong Pharmaceutical

Mylan

Pfizer

Hunan Dinuo Pharmaceutical

Fuyuan Pharmaceutical

Bayer

Aobang Pharmaceutical

Gilead Sciences

Dr. Reddy's Laboratories

Cipla

Abbott Laboratories

Allylamines Antifungal Drugs Segment by Type

Terbinafine

Naftifine

Butenafine

Others

Allylamines Antifungal Drugs Segment by Application

Tinea Capitis

Dermatophytosis

Candidiasis

Tinea Versicolor

Others

Allylamines Antifungal Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Allylamines Antifungal Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Allylamines Antifungal Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Allylamines Antifungal Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Allylamines Antifungal Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Allylamines Antifungal Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Allylamines Antifungal Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Allylamines Antifungal Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Terbinafine Major Manufacturers Table 3. Naftifine Major Manufacturers Table 4. Butenafine Major Manufacturers Table 5. Others Major Manufacturers Table 6. Global Allylamines Antifungal Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Tinea Capitis Major Manufacturers Table 8. Dermatophytosis Major Manufacturers Table 9. Candidiasis Major Manufacturers Table 10. Tinea Versicolor Major Manufacturers Table 11. Others Major Manufacturers Table 12. Allylamines Antifungal Drugs Industry Trends Table 13. Allylamines Antifungal Drugs Industry Drivers Table 14. Allylamines Antifungal Drugs Industry Opportunities and Challenges Table 15. Allylamines Antifungal Drugs Industry Restraints Table 16. Global Allylamines Antifungal Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Allylamines Antifungal Drugs Revenue by Region (2021-2026) & (US$ Million) Table 18. Global Allylamines Antifungal Drugs Revenue by Region (2027-2032) & (US$ Million) Table 19. Global Allylamines Antifungal Drugs Revenue Market Share by Region (2021-2026) Table 20. Global Allylamines Antifungal Drugs Revenue Market Share by Region (2027-2032) Table 21. Global Allylamines Antifungal Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (units) Table 22. Global Allylamines Antifungal Drugs Sales by Region (2021-2026) & (units) Table 23. Global Allylamines Antifungal Drugs Sales by Region (2027-2032) & (units) Table 24. Global Allylamines Antifungal Drugs Sales Market Share by Region (2021-2026) Table 25. Global Allylamines Antifungal Drugs Sales Market Share by Region (2027-2032) Table 26. Global Allylamines Antifungal Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Allylamines Antifungal Drugs Revenue Market Share by Manufacturers (2021-2026) Table 28. Global Allylamines Antifungal Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Allylamines Antifungal Drugs Sales Market Share by Manufacturers (2021-2026) Table 30. Global Allylamines Antifungal Drugs Sales Price (USD/unit) of Manufacturers (2021-2026) Table 31. Global Allylamines Antifungal Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 32. Global Allylamines Antifungal Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 33. Global Allylamines Antifungal Drugs Manufacturers, Product Type & Application Table 34. Global Allylamines Antifungal Drugs Manufacturers' Establishment Date Table 35. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 36. Global Allylamines Antifungal Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 37. Global Allylamines Antifungal Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Allylamines Antifungal Drugs Revenue by Type (2021-2026) & (US$ Million) Table 39. Global Allylamines Antifungal Drugs Revenue by Type (2027-2032) & (US$ Million) Table 40. Global Allylamines Antifungal Drugs Revenue Market Share by Type (2021-2026) Table 41. Global Allylamines Antifungal Drugs Revenue Market Share by Type (2027-2032) Table 42. Global Allylamines Antifungal Drugs Sales by Type 2021 VS 2025 VS 2032 (units) Table 43. Global Allylamines Antifungal Drugs Sales by Type (2021-2026) & (units) Table 44. Global Allylamines Antifungal Drugs Sales by Type (2027-2032) & (units) Table 45. Global Allylamines Antifungal Drugs Sales Market Share by Type (2021-2026) Table 46. Global Allylamines Antifungal Drugs Sales Market Share by Type (2027-2032) Table 47. Global Allylamines Antifungal Drugs Price by Type (2021-2026) & (USD/unit) Table 48. Global Allylamines Antifungal Drugs Price by Type (2027-2032) & (USD/unit) Table 49. Global Allylamines Antifungal Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Allylamines Antifungal Drugs Revenue by Application (2021-2026) & (US$ Million) Table 51. Global Allylamines Antifungal Drugs Revenue by Application (2027-2032) & (US$ Million) Table 52. Global Allylamines Antifungal Drugs Revenue Market Share by Application (2021-2026) Table 53. Global Allylamines Antifungal Drugs Revenue Market Share by Application (2027-2032) Table 54. Global Allylamines Antifungal Drugs Sales by Application 2021 VS 2025 VS 2032 (units) Table 55. Global Allylamines Antifungal Drugs Sales by Application (2021-2026) & (units) Table 56. Global Allylamines Antifungal Drugs Sales by Application (2027-2032) & (units) Table 57. Global Allylamines Antifungal Drugs Sales Market Share by Application (2021-2026) Table 58. Global Allylamines Antifungal Drugs Sales Market Share by Application (2027-2032) Table 59. Global Allylamines Antifungal Drugs Price by Application (2021-2026) & (USD/unit) Table 60. Global Allylamines Antifungal Drugs Price by Application (2027-2032) & (USD/unit) Table 61. Chongqing Huapont Pharmaceutical Company Information Table 62. Chongqing Huapont Pharmaceutical Business Overview Table 63. Chongqing Huapont Pharmaceutical Allylamines Antifungal Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 64. Chongqing Huapont Pharmaceutical Allylamines Antifungal Drugs Product Portfolio Table 65. Chongqing Huapont Pharmaceutical Recent Development Table 66. Yangtze River Pharmaceutical Group Company Information Table 67. Yangtze River Pharmaceutical Group Business Overview Table 68. Yangtze River Pharmaceutical Group Allylamines Antifungal Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 69. Yangtze River Pharmaceutical Group Allylamines Antifungal Drugs Product Portfolio Table 70. Yangtze River Pharmaceutical Group Recent Development Table 71. Xiuzheng Pharmaceutical Group Company Information Table 72. Xiuzheng Pharmaceutical Group Business Overview Table 73. Xiuzheng Pharmaceutical Group Allylamines Antifungal Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 74. Xiuzheng Pharmaceutical Group Allylamines Antifungal Drugs Product Portfolio Table 75. Xiuzheng Pharmaceutical Group Recent Development Table 76. Tongyao Pharmaceutical Group Company Information Table 77. Tongyao Pharmaceutical Group Business Overview Table 78. Tongyao Pharmaceutical Group Allylamines Antifungal Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 79. Tongyao Pharmaceutical Group Allylamines Antifungal Drugs Product Portfolio Table 80. Tongyao Pharmaceutical Group Recent Development Table 81. Teva Company Information Table 82. Teva Business Overview Table 83. Teva Allylamines Antifungal Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 84. Teva Allylamines Antifungal Drugs Product Portfolio Table 85. Teva Recent Development Table 86. Shandong Chenxin Pharmaceutical Company Information Table 87. Shandong Chenxin Pharmaceutical Business Overview Table 88. Shandong Chenxin Pharmaceutical Allylamines Antifungal Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. Shandong Chenxin Pharmaceutical Allylamines Antifungal Drugs Product Portfolio Table 90. Shandong Chenxin Pharmaceutical Recent Development Table 91. Sandoz Company Information Table 92. Sandoz Business Overview Table 93. Sandoz Allylamines Antifungal Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Sandoz Allylamines Antifungal Drugs Product Portfolio Table 95. Sandoz Recent Development Table 96. Qilu Pharmaceutical Company Information Table 97. Qilu Pharmaceutical Business Overview Table 98. Qilu Pharmaceutical Allylamines Antifungal Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Qilu Pharmaceutical Allylamines Antifungal Drugs Product Portfolio Table 100. Qilu Pharmaceutical Recent Development Table 101. Novartis Company Information Table 102. Novartis Business Overview Table 103. Novartis Allylamines Antifungal Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Novartis Allylamines Antifungal Drugs Product Portfolio Table 105. Novartis Recent Development Table 106. Nanjing Chenggong Pharmaceutical Company Information Table 107. Nanjing Chenggong Pharmaceutical Business Overview Table 108. Nanjing Chenggong Pharmaceutical Allylamines Antifungal Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Nanjing Chenggong Pharmaceutical Allylamines Antifungal Drugs Product Portfolio Table 110. Nanjing Chenggong Pharmaceutical Recent Development Table 111. Mylan Company Information Table 112. Mylan Business Overview Table 113. Mylan Allylamines Antifungal Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Mylan Allylamines Antifungal Drugs Product Portfolio Table 115. Mylan Recent Development Table 116. Pfizer Company Information Table 117. Pfizer Business Overview Table 118. Pfizer Allylamines Antifungal Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Pfizer Allylamines Antifungal Drugs Product Portfolio Table 120. Pfizer Recent Development Table 121. Hunan Dinuo Pharmaceutical Company Information Table 122. Hunan Dinuo Pharmaceutical Business Overview Table 123. Hunan Dinuo Pharmaceutical Allylamines Antifungal Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Hunan Dinuo Pharmaceutical Allylamines Antifungal Drugs Product Portfolio Table 125. Hunan Dinuo Pharmaceutical Recent Development Table 126. Fuyuan Pharmaceutical Company Information Table 127. Fuyuan Pharmaceutical Business Overview Table 128. Fuyuan Pharmaceutical Allylamines Antifungal Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. Fuyuan Pharmaceutical Allylamines Antifungal Drugs Product Portfolio Table 130. Fuyuan Pharmaceutical Recent Development Table 131. Bayer Company Information Table 132. Bayer Business Overview Table 133. Bayer Allylamines Antifungal Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. Bayer Allylamines Antifungal Drugs Product Portfolio Table 135. Bayer Recent Development Table 136. Aobang Pharmaceutical Company Information Table 137. Aobang Pharmaceutical Business Overview Table 138. Aobang Pharmaceutical Allylamines Antifungal Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 139. Aobang Pharmaceutical Allylamines Antifungal Drugs Product Portfolio Table 140. Aobang Pharmaceutical Recent Development Table 141. Gilead Sciences Company Information Table 142. Gilead Sciences Business Overview Table 143. Gilead Sciences Allylamines Antifungal Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 144. Gilead Sciences Allylamines Antifungal Drugs Product Portfolio Table 145. Gilead Sciences Recent Development Table 146. Dr. Reddy's Laboratories Company Information Table 147. Dr. Reddy's Laboratories Business Overview Table 148. Dr. Reddy's Laboratories Allylamines Antifungal Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 149. Dr. Reddy's Laboratories Allylamines Antifungal Drugs Product Portfolio Table 150. Dr. Reddy's Laboratories Recent Development Table 151. Cipla Company Information Table 152. Cipla Business Overview Table 153. Cipla Allylamines Antifungal Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 154. Cipla Allylamines Antifungal Drugs Product Portfolio Table 155. Cipla Recent Development Table 156. Abbott Laboratories Company Information Table 157. Abbott Laboratories Business Overview Table 158. Abbott Laboratories Allylamines Antifungal Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 159. Abbott Laboratories Allylamines Antifungal Drugs Product Portfolio Table 160. Abbott Laboratories Recent Development Table 161. North America Allylamines Antifungal Drugs Revenue by Type (2021-2026) & (US$ Million) Table 162. North America Allylamines Antifungal Drugs Revenue by Type (2027-2032) & (US$ Million) Table 163. North America Allylamines Antifungal Drugs Sales by Type (2021-2026) & (units) Table 164. North America Allylamines Antifungal Drugs Sales by Type (2027-2032) & (units) Table 165. North America Allylamines Antifungal Drugs Sales Price by Type (2021-2026) & (USD/unit) Table 166. North America Allylamines Antifungal Drugs Sales Price by Type (2027-2032) & (USD/unit) Table 167. North America Allylamines Antifungal Drugs Revenue by Application (2021-2026) & (US$ Million) Table 168. North America Allylamines Antifungal Drugs Revenue by Application (2027-2032) & (US$ Million) Table 169. North America Allylamines Antifungal Drugs Sales by Application (2021-2026) & (units) Table 170. North America Allylamines Antifungal Drugs Sales by Application (2027-2032) & (units) Table 171. North America Allylamines Antifungal Drugs Sales Price by Application (2021-2026) & (USD/unit) Table 172. North America Allylamines Antifungal Drugs Sales Price by Application (2027-2032) & (USD/unit) Table 173. North America Allylamines Antifungal Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 174. North America Allylamines Antifungal Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 175. North America Allylamines Antifungal Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 176. North America Allylamines Antifungal Drugs Sales by Country (2021 VS 2025 VS 2032) & (units) Table 177. North America Allylamines Antifungal Drugs Sales by Country (2021-2026) & (units) Table 178. North America Allylamines Antifungal Drugs Sales by Country (2027-2032) & (units) Table 179. North America Allylamines Antifungal Drugs Sales Price by Country (2021-2026) & (USD/unit) Table 180. North America Allylamines Antifungal Drugs Sales Price by Country (2027-2032) & (USD/unit) Table 181. United States Allylamines Antifungal Drugs Revenue (2021-2032) & (US$ Million) Table 182. Canada Allylamines Antifungal Drugs Revenue (2021-2032) & (US$ Million) Table 183. Mexico Allylamines Antifungal Drugs Revenue (2021-2032) & (US$ Million) Table 184. Europe Allylamines Antifungal Drugs Revenue by Type (2021-2026) & (US$ Million) Table 185. Europe Allylamines Antifungal Drugs Revenue by Type (2027-2032) & (US$ Million) Table 186. Europe Allylamines Antifungal Drugs Sales by Type (2021-2026) & (units) Table 187. Europe Allylamines Antifungal Drugs Sales by Type (2027-2032) & (units) Table 188. Europe Allylamines Antifungal Drugs Sales Price by Type (2021-2026) & (USD/unit) Table 189. Europe Allylamines Antifungal Drugs Sales Price by Type (2027-2032) & (USD/unit) Table 190. Europe Allylamines Antifungal Drugs Revenue by Application (2021-2026) & (US$ Million) Table 191. Europe Allylamines Antifungal Drugs Revenue by Application (2027-2032) & (US$ Million) Table 192. Europe Allylamines Antifungal Drugs Sales by Application (2021-2026) & (units) Table 193. Europe Allylamines Antifungal Drugs Sales by Application (2027-2032) & (units) Table 194. Europe Allylamines Antifungal Drugs Sales Price by Application (2021-2026) & (USD/unit) Table 195. Europe Allylamines Antifungal Drugs Sales Price by Application (2027-2032) & (USD/unit) Table 196. Europe Allylamines Antifungal Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 197. Europe Allylamines Antifungal Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 198. Europe Allylamines Antifungal Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 199. Europe Allylamines Antifungal Drugs Sales by Country (2021 VS 2025 VS 2032) & (units) Table 200. Europe Allylamines Antifungal Drugs Sales by Country (2021-2026) & (units) Table 201. Europe Allylamines Antifungal Drugs Sales by Country (2027-2032) & (units) Table 202. Europe Allylamines Antifungal Drugs Sales Price by Country (2021-2026) & (USD/unit) Table 203. Europe Allylamines Antifungal Drugs Sales Price by Country (2027-2032) & (USD/unit) Table 204. Germany Allylamines Antifungal Drugs Revenue (2021-2032) & (US$ Million) Table 205. France Allylamines Antifungal Drugs Revenue (2021-2032) & (US$ Million) Table 206. U.K. Allylamines Antifungal Drugs Revenue (2021-2032) & (US$ Million) Table 207. Italy Allylamines Antifungal Drugs Revenue (2021-2032) & (US$ Million) Table 208. Russia Allylamines Antifungal Drugs Revenue (2021-2032) & (US$ Million) Table 209. Spain Allylamines Antifungal Drugs Revenue (2021-2032) & (US$ Million) Table 210. Netherlands Allylamines Antifungal Drugs Revenue (2021-2032) & (US$ Million) Table 211. Switzerland Allylamines Antifungal Drugs Revenue (2021-2032) & (US$ Million) Table 212. Sweden Allylamines Antifungal Drugs Revenue (2021-2032) & (US$ Million) Table 213. Poland Allylamines Antifungal Drugs Revenue (2021-2032) & (US$ Million) Table 214. China Allylamines Antifungal Drugs Revenue by Type (2021-2026) & (US$ Million) Table 215. China Allylamines Antifungal Drugs Revenue by Type (2027-2032) & (US$ Million) Table 216. China Allylamines Antifungal Drugs Sales by Type (2021-2026) & (units) Table 217. China Allylamines Antifungal Drugs Sales by Type (2027-2032) & (units) Table 218. China Allylamines Antifungal Drugs Sales Price by Type (2021-2026) & (USD/unit) Table 219. China Allylamines Antifungal Drugs Sales Price by Type (2027-2032) & (USD/unit) Table 220. China Allylamines Antifungal Drugs Revenue by Application (2021-2026) & (US$ Million) Table 221. China Allylamines Antifungal Drugs Revenue by Application (2027-2032) & (US$ Million) Table 222. China Allylamines Antifungal Drugs Sales by Application (2021-2026) & (units) Table 223. China Allylamines Antifungal Drugs Sales by Application (2027-2032) & (units) Table 224. China Allylamines Antifungal Drugs Sales Price by Application (2021-2026) & (USD/unit) Table 225. China Allylamines Antifungal Drugs Sales Price by Application (2027-2032) & (USD/unit) Table 226. Asia Allylamines Antifungal Drugs Revenue by Type (2021-2026) & (US$ Million) Table 227. Asia Allylamines Antifungal Drugs Revenue by Type (2027-2032) & (US$ Million) Table 228. Asia Allylamines Antifungal Drugs Sales by Type (2021-2026) & (units) Table 229. Asia Allylamines Antifungal Drugs Sales by Type (2027-2032) & (units) Table 230. Asia Allylamines Antifungal Drugs Sales Price by Type (2021-2026) & (USD/unit) Table 231. Asia Allylamines Antifungal Drugs Sales Price by Type (2027-2032) & (USD/unit) Table 232. Asia Allylamines Antifungal Drugs Revenue by Application (2021-2026) & (US$ Million) Table 233. Asia Allylamines Antifungal Drugs Revenue by Application (2027-2032) & (US$ Million) Table 234. Asia Allylamines Antifungal Drugs Sales by Application (2021-2026) & (units) Table 235. Asia Allylamines Antifungal Drugs Sales by Application (2027-2032) & (units) Table 236. Asia Allylamines Antifungal Drugs Sales Price by Application (2021-2026) & (USD/unit) Table 237. Asia Allylamines Antifungal Drugs Sales Price by Application (2027-2032) & (USD/unit) Table 238. Asia Allylamines Antifungal Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 239. Asia Allylamines Antifungal Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 240. Asia Allylamines Antifungal Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 241. Asia Allylamines Antifungal Drugs Sales by Country (2021 VS 2025 VS 2032) & (units) Table 242. Asia Allylamines Antifungal Drugs Sales by Country (2021-2026) & (units) Table 243. Asia Allylamines Antifungal Drugs Sales by Country (2027-2032) & (units) Table 244. Asia Allylamines Antifungal Drugs Sales Price by Country (2021-2026) & (USD/unit) Table 245. Asia Allylamines Antifungal Drugs Sales Price by Country (2027-2032) & (USD/unit) Table 246. Japan Allylamines Antifungal Drugs Revenue (2021-2032) & (US$ Million) Table 247. South Korea Allylamines Antifungal Drugs Revenue (2021-2032) & (US$ Million) Table 248. India Allylamines Antifungal Drugs Revenue (2021-2032) & (US$ Million) Table 249. Australia Allylamines Antifungal Drugs Revenue (2021-2032) & (US$ Million) Table 250. Taiwan Allylamines Antifungal Drugs Revenue (2021-2032) & (US$ Million) Table 251. Southeast Asia Allylamines Antifungal Drugs Revenue (2021-2032) & (US$ Million) Table 252. SAMEA Allylamines Antifungal Drugs Revenue by Type (2021-2026) & (US$ Million) Table 253. SAMEA Allylamines Antifungal Drugs Revenue by Type (2027-2032) & (US$ Million) Table 254. SAMEA Allylamines Antifungal Drugs Sales by Type (2021-2026) & (units) Table 255. SAMEA Allylamines Antifungal Drugs Sales by Type (2027-2032) & (units) Table 256. SAMEA Allylamines Antifungal Drugs Sales Price by Type (2021-2026) & (USD/unit) Table 257. SAMEA Allylamines Antifungal Drugs Sales Price by Type (2027-2032) & (USD/unit) Table 258. SAMEA Allylamines Antifungal Drugs Revenue by Application (2021-2026) & (US$ Million) Table 259. SAMEA Allylamines Antifungal Drugs Revenue by Application (2027-2032) & (US$ Million) Table 260. SAMEA Allylamines Antifungal Drugs Sales by Application (2021-2026) & (units) Table 261. SAMEA Allylamines Antifungal Drugs Sales by Application (2027-2032) & (units) Table 262. SAMEA Allylamines Antifungal Drugs Sales Price by Application (2021-2026) & (USD/unit) Table 263. SAMEA Allylamines Antifungal Drugs Sales Price by Application (2027-2032) & (USD/unit) Table 264. SAMEA Allylamines Antifungal Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 265. SAMEA Allylamines Antifungal Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 266. SAMEA Allylamines Antifungal Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 267. SAMEA Allylamines Antifungal Drugs Sales by Country (2021 VS 2025 VS 2032) & (units) Table 268. SAMEA Allylamines Antifungal Drugs Sales by Country (2021-2026) & (units) Table 269. SAMEA Allylamines Antifungal Drugs Sales by Country (2027-2032) & (units) Table 270. SAMEA Allylamines Antifungal Drugs Sales Price by Country (2021-2026) & (USD/unit) Table 271. SAMEA Allylamines Antifungal Drugs Sales Price by Country (2027-2032) & (USD/unit) Table 272. Brazil Allylamines Antifungal Drugs Revenue (2021-2032) & (US$ Million) Table 273. Argentina Allylamines Antifungal Drugs Revenue (2021-2032) & (US$ Million) Table 274. Chile Allylamines Antifungal Drugs Revenue (2021-2032) & (US$ Million) Table 275. Colombia Allylamines Antifungal Drugs Revenue (2021-2032) & (US$ Million) Table 276. Peru Allylamines Antifungal Drugs Revenue (2021-2032) & (US$ Million) Table 277. Saudi Arabia Allylamines Antifungal Drugs Revenue (2021-2032) & (US$ Million) Table 278. Israel Allylamines Antifungal Drugs Revenue (2021-2032) & (US$ Million) Table 279. UAE Allylamines Antifungal Drugs Revenue (2021-2032) & (US$ Million) Table 280. Turkey Allylamines Antifungal Drugs Revenue (2021-2032) & (US$ Million) Table 281. Iran Allylamines Antifungal Drugs Revenue (2021-2032) & (US$ Million) Table 282. Egypt Allylamines Antifungal Drugs Revenue (2021-2032) & (US$ Million) Table 283. Key Raw Materials Table 284. Raw Materials Key Suppliers Table 285. Allylamines Antifungal Drugs Distributors List Table 286. Allylamines Antifungal Drugs Customers List Table 287. Research Programs/Design for This Report Table 288. Authors List of This Report Table 289. Secondary Sources Table 290. Primary Sources List of Figures Figure 1. Allylamines Antifungal Drugs Image Figure 2. Global Allylamines Antifungal Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Allylamines Antifungal Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Terbinafine Image Figure 5. Naftifine Image Figure 6. Butenafine Image Figure 7. Others Image Figure 8. Global Allylamines Antifungal Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Allylamines Antifungal Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 10. Tinea Capitis Image Figure 11. Dermatophytosis Image Figure 12. Candidiasis Image Figure 13. Tinea Versicolor Image Figure 14. Others Image Figure 15. Global Allylamines Antifungal Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Allylamines Antifungal Drugs Revenue (2021-2032) & (US$ Million) Figure 17. Global Allylamines Antifungal Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Allylamines Antifungal Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 19. Global Allylamines Antifungal Drugs Revenue Market Share by Region (2021-2032) Figure 20. Global Allylamines Antifungal Drugs Sales (2021-2032) & (units) Figure 21. Global Allylamines Antifungal Drugs Sales by Region: 2021 VS 2025 VS 2032 (units) Figure 22. Global Allylamines Antifungal Drugs Sales Market Share by Region (2021-2032) Figure 23. US & Canada & Mexico Allylamines Antifungal Drugs Sales YoY (2021-2032) & (units) Figure 24. Europe Allylamines Antifungal Drugs Sales YoY (2021-2032) & (units) Figure 25. China Allylamines Antifungal Drugs Sales YoY (2021-2032) & (units) Figure 26. Asia (Excluding China) Allylamines Antifungal Drugs Sales YoY (2021-2032) & (units) Figure 27. South America, Middle East and Africa Allylamines Antifungal Drugs Sales YoY (2021-2032) & (units) Figure 28. Global Allylamines Antifungal Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 29. Global Allylamines Antifungal Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 30. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Global Allylamines Antifungal Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 32. Global Allylamines Antifungal Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Allylamines Antifungal Drugs Revenue Market Share by Type (2021-2032) Figure 34. Global Allylamines Antifungal Drugs Sales by Type (2021 VS 2025 VS 2032) & (units) Figure 35. Global Allylamines Antifungal Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 36. Global Allylamines Antifungal Drugs Sales Market Share by Type (2021-2032) Figure 37. Global Allylamines Antifungal Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 38. Global Allylamines Antifungal Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Allylamines Antifungal Drugs Revenue Market Share by Application (2021-2032) Figure 40. Global Allylamines Antifungal Drugs Sales by Application (2021 VS 2025 VS 2032) & (units) Figure 41. Global Allylamines Antifungal Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 42. Global Allylamines Antifungal Drugs Sales Market Share by Application (2021-2032) Figure 43. North America Allylamines Antifungal Drugs Revenue Share by Type (2021-2032) Figure 44. North America Allylamines Antifungal Drugs Sales Share by Type (2021-2032) Figure 45. North America Allylamines Antifungal Drugs Revenue Share by Application (2021-2032) Figure 46. North America Allylamines Antifungal Drugs Sales Share by Application (2021-2032) Figure 47. North America Allylamines Antifungal Drugs Revenue Share by Country (2021-2032) Figure 48. North America Allylamines Antifungal Drugs Sales Share by Country (2021-2032) Figure 49. Europe Allylamines Antifungal Drugs Revenue Share by Type (2021-2032) Figure 50. Europe Allylamines Antifungal Drugs Sales Share by Type (2021-2032) Figure 51. Europe Allylamines Antifungal Drugs Revenue Share by Application (2021-2032) Figure 52. Europe Allylamines Antifungal Drugs Sales Share by Application (2021-2032) Figure 53. Europe Allylamines Antifungal Drugs Revenue Share by Country (2021-2032) Figure 54. Europe Allylamines Antifungal Drugs Sales Share by Country (2021-2032) Figure 55. China Allylamines Antifungal Drugs Revenue Share by Type (2021-2032) Figure 56. China Allylamines Antifungal Drugs Sales Share by Type (2021-2032) Figure 57. China Allylamines Antifungal Drugs Revenue Share by Application (2021-2032) Figure 58. China Allylamines Antifungal Drugs Sales Share by Application (2021-2032) Figure 59. Asia Allylamines Antifungal Drugs Revenue Share by Type (2021-2032) Figure 60. Asia Allylamines Antifungal Drugs Sales Share by Type (2021-2032) Figure 61. Asia Allylamines Antifungal Drugs Revenue Share by Application (2021-2032) Figure 62. Asia Allylamines Antifungal Drugs Sales Share by Application (2021-2032) Figure 63. Asia Allylamines Antifungal Drugs Revenue Share by Country (2021-2032) Figure 64. Asia Allylamines Antifungal Drugs Sales Share by Country (2021-2032) Figure 65. SAMEA Allylamines Antifungal Drugs Revenue Share by Type (2021-2032) Figure 66. SAMEA Allylamines Antifungal Drugs Sales Share by Type (2021-2032) Figure 67. SAMEA Allylamines Antifungal Drugs Revenue Share by Application (2021-2032) Figure 68. SAMEA Allylamines Antifungal Drugs Sales Share by Application (2021-2032) Figure 69. SAMEA Allylamines Antifungal Drugs Revenue Share by Country (2021-2032) Figure 70. SAMEA Allylamines Antifungal Drugs Sales Share by Country (2021-2032) Figure 71. Allylamines Antifungal Drugs Value Chain Figure 72. Manufacturing Cost Structure Figure 73. Allylamines Antifungal Drugs Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • Terbinafine
  • Naftifine
  • Butenafine
  • Others
Applications
  • Tinea Capitis
  • Dermatophytosis
  • Candidiasis
  • Tinea Versicolor
  • Others
Companies covered
  • Chongqing Huapont Pharmaceutical
  • Yangtze River Pharmaceutical Group
  • Xiuzheng Pharmaceutical Group
  • Tongyao Pharmaceutical Group
  • Teva
  • Shandong Chenxin Pharmaceutical
  • Sandoz
  • Qilu Pharmaceutical
  • Novartis
  • Nanjing Chenggong Pharmaceutical
  • Mylan
  • Pfizer
  • Hunan Dinuo Pharmaceutical
  • Fuyuan Pharmaceutical
  • Bayer
  • Aobang Pharmaceutical
  • Gilead Sciences
  • Dr. Reddy's Laboratories
  • Cipla
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Allylamines Antifungal Drugs Market by Type
  3. 1.2.1 Global Allylamines Antifungal Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Terbinafine
  5. 1.2.3 Naftifine
  6. 1.2.4 Butenafine
  7. 1.2.5 Others
  8. 1.3 Allylamines Antifungal Drugs Market by Application
  9. 1.3.1 Global Allylamines Antifungal Drugs Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Tinea Capitis
  11. 1.3.3 Dermatophytosis
  12. 1.3.4 Candidiasis
  13. 1.3.5 Tinea Versicolor
  14. 1.3.6 Others
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Allylamines Antifungal Drugs Market Dynamics
  1. 2.1 Allylamines Antifungal Drugs Industry Trends
  2. 2.2 Allylamines Antifungal Drugs Industry Drivers
  3. 2.3 Allylamines Antifungal Drugs Industry Opportunities and Challenges
  4. 2.4 Allylamines Antifungal Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Allylamines Antifungal Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Allylamines Antifungal Drugs Revenue by Region
  3. 3.2.1 Global Allylamines Antifungal Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Allylamines Antifungal Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Allylamines Antifungal Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Allylamines Antifungal Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Allylamines Antifungal Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Allylamines Antifungal Drugs Sales by Region
  9. 3.4.1 Global Allylamines Antifungal Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Allylamines Antifungal Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Allylamines Antifungal Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Allylamines Antifungal Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Allylamines Antifungal Drugs Revenue by Manufacturers
  2. 4.1.1 Global Allylamines Antifungal Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Allylamines Antifungal Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Allylamines Antifungal Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Allylamines Antifungal Drugs Sales by Manufacturers
  6. 4.2.1 Global Allylamines Antifungal Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Allylamines Antifungal Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Allylamines Antifungal Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Allylamines Antifungal Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Allylamines Antifungal Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Allylamines Antifungal Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Allylamines Antifungal Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Allylamines Antifungal Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Allylamines Antifungal Drugs Market CR5 and HHI
  16. 4.8.2 2025 Allylamines Antifungal Drugs Tier 1, Tier 2, and Tier 3
5 Allylamines Antifungal Drugs Market by Type
  1. 5.1 Global Allylamines Antifungal Drugs Revenue by Type
  2. 5.1.1 Global Allylamines Antifungal Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Allylamines Antifungal Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Allylamines Antifungal Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Allylamines Antifungal Drugs Sales by Type
  6. 5.2.1 Global Allylamines Antifungal Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Allylamines Antifungal Drugs Sales by Type (2021-2032) & (units)
  8. 5.2.3 Global Allylamines Antifungal Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Allylamines Antifungal Drugs Price by Type
6 Allylamines Antifungal Drugs Market by Application
  1. 6.1 Global Allylamines Antifungal Drugs Revenue by Application
  2. 6.1.1 Global Allylamines Antifungal Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Allylamines Antifungal Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Allylamines Antifungal Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Allylamines Antifungal Drugs Sales by Application
  6. 6.2.1 Global Allylamines Antifungal Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Allylamines Antifungal Drugs Sales by Application (2021-2032) & (units)
  8. 6.2.3 Global Allylamines Antifungal Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Allylamines Antifungal Drugs Price by Application
7 Company Profiles
  1. 7.1 Chongqing Huapont Pharmaceutical
  2. 7.1.1 Chongqing Huapont Pharmaceutical Company Information
  3. 7.1.2 Chongqing Huapont Pharmaceutical Business Overview
  4. 7.1.3 Chongqing Huapont Pharmaceutical Allylamines Antifungal Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Chongqing Huapont Pharmaceutical Allylamines Antifungal Drugs Product Portfolio
  6. 7.1.5 Chongqing Huapont Pharmaceutical Recent Developments
  7. 7.2 Yangtze River Pharmaceutical Group
  8. 7.2.1 Yangtze River Pharmaceutical Group Company Information
  9. 7.2.2 Yangtze River Pharmaceutical Group Business Overview
  10. 7.2.3 Yangtze River Pharmaceutical Group Allylamines Antifungal Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Yangtze River Pharmaceutical Group Allylamines Antifungal Drugs Product Portfolio
  12. 7.2.5 Yangtze River Pharmaceutical Group Recent Developments
  13. 7.3 Xiuzheng Pharmaceutical Group
  14. 7.3.1 Xiuzheng Pharmaceutical Group Company Information
  15. 7.3.2 Xiuzheng Pharmaceutical Group Business Overview
  16. 7.3.3 Xiuzheng Pharmaceutical Group Allylamines Antifungal Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Xiuzheng Pharmaceutical Group Allylamines Antifungal Drugs Product Portfolio
  18. 7.3.5 Xiuzheng Pharmaceutical Group Recent Developments
  19. 7.4 Tongyao Pharmaceutical Group
  20. 7.4.1 Tongyao Pharmaceutical Group Company Information
  21. 7.4.2 Tongyao Pharmaceutical Group Business Overview
  22. 7.4.3 Tongyao Pharmaceutical Group Allylamines Antifungal Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Tongyao Pharmaceutical Group Allylamines Antifungal Drugs Product Portfolio
  24. 7.4.5 Tongyao Pharmaceutical Group Recent Developments
  25. 7.5 Teva
  26. 7.5.1 Teva Company Information
  27. 7.5.2 Teva Business Overview
  28. 7.5.3 Teva Allylamines Antifungal Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Teva Allylamines Antifungal Drugs Product Portfolio
  30. 7.5.5 Teva Recent Developments
  31. 7.6 Shandong Chenxin Pharmaceutical
  32. 7.6.1 Shandong Chenxin Pharmaceutical Company Information
  33. 7.6.2 Shandong Chenxin Pharmaceutical Business Overview
  34. 7.6.3 Shandong Chenxin Pharmaceutical Allylamines Antifungal Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Shandong Chenxin Pharmaceutical Allylamines Antifungal Drugs Product Portfolio
  36. 7.6.5 Shandong Chenxin Pharmaceutical Recent Developments
  37. 7.7 Sandoz
  38. 7.7.1 Sandoz Company Information
  39. 7.7.2 Sandoz Business Overview
  40. 7.7.3 Sandoz Allylamines Antifungal Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Sandoz Allylamines Antifungal Drugs Product Portfolio
  42. 7.7.5 Sandoz Recent Developments
  43. 7.8 Qilu Pharmaceutical
  44. 7.8.1 Qilu Pharmaceutical Company Information
  45. 7.8.2 Qilu Pharmaceutical Business Overview
  46. 7.8.3 Qilu Pharmaceutical Allylamines Antifungal Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Qilu Pharmaceutical Allylamines Antifungal Drugs Product Portfolio
  48. 7.8.5 Qilu Pharmaceutical Recent Developments
  49. 7.9 Novartis
  50. 7.9.1 Novartis Company Information
  51. 7.9.2 Novartis Business Overview
  52. 7.9.3 Novartis Allylamines Antifungal Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Novartis Allylamines Antifungal Drugs Product Portfolio
  54. 7.9.5 Novartis Recent Developments
  55. 7.10 Nanjing Chenggong Pharmaceutical
  56. 7.10.1 Nanjing Chenggong Pharmaceutical Company Information
  57. 7.10.2 Nanjing Chenggong Pharmaceutical Business Overview
  58. 7.10.3 Nanjing Chenggong Pharmaceutical Allylamines Antifungal Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Nanjing Chenggong Pharmaceutical Allylamines Antifungal Drugs Product Portfolio
  60. 7.10.5 Nanjing Chenggong Pharmaceutical Recent Developments
  61. 7.11 Mylan
  62. 7.11.1 Mylan Company Information
  63. 7.11.2 Mylan Business Overview
  64. 7.11.3 Mylan Allylamines Antifungal Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Mylan Allylamines Antifungal Drugs Product Portfolio
  66. 7.11.5 Mylan Recent Developments
  67. 7.12 Pfizer
  68. 7.12.1 Pfizer Company Information
  69. 7.12.2 Pfizer Business Overview
  70. 7.12.3 Pfizer Allylamines Antifungal Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Pfizer Allylamines Antifungal Drugs Product Portfolio
  72. 7.12.5 Pfizer Recent Developments
  73. 7.13 Hunan Dinuo Pharmaceutical
  74. 7.13.1 Hunan Dinuo Pharmaceutical Company Information
  75. 7.13.2 Hunan Dinuo Pharmaceutical Business Overview
  76. 7.13.3 Hunan Dinuo Pharmaceutical Allylamines Antifungal Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Hunan Dinuo Pharmaceutical Allylamines Antifungal Drugs Product Portfolio
  78. 7.13.5 Hunan Dinuo Pharmaceutical Recent Developments
  79. 7.14 Fuyuan Pharmaceutical
  80. 7.14.1 Fuyuan Pharmaceutical Company Information
  81. 7.14.2 Fuyuan Pharmaceutical Business Overview
  82. 7.14.3 Fuyuan Pharmaceutical Allylamines Antifungal Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Fuyuan Pharmaceutical Allylamines Antifungal Drugs Product Portfolio
  84. 7.14.5 Fuyuan Pharmaceutical Recent Developments
  85. 7.15 Bayer
  86. 7.15.1 Bayer Company Information
  87. 7.15.2 Bayer Business Overview
  88. 7.15.3 Bayer Allylamines Antifungal Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Bayer Allylamines Antifungal Drugs Product Portfolio
  90. 7.15.5 Bayer Recent Developments
  91. 7.16 Aobang Pharmaceutical
  92. 7.16.1 Aobang Pharmaceutical Company Information
  93. 7.16.2 Aobang Pharmaceutical Business Overview
  94. 7.16.3 Aobang Pharmaceutical Allylamines Antifungal Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Aobang Pharmaceutical Allylamines Antifungal Drugs Product Portfolio
  96. 7.16.5 Aobang Pharmaceutical Recent Developments
  97. 7.17 Gilead Sciences
  98. 7.17.1 Gilead Sciences Company Information
  99. 7.17.2 Gilead Sciences Business Overview
  100. 7.17.3 Gilead Sciences Allylamines Antifungal Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Gilead Sciences Allylamines Antifungal Drugs Product Portfolio
  102. 7.17.5 Gilead Sciences Recent Developments
  103. 7.18 Dr. Reddy's Laboratories
  104. 7.18.1 Dr. Reddy's Laboratories Company Information
  105. 7.18.2 Dr. Reddy's Laboratories Business Overview
  106. 7.18.3 Dr. Reddy's Laboratories Allylamines Antifungal Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Dr. Reddy's Laboratories Allylamines Antifungal Drugs Product Portfolio
  108. 7.18.5 Dr. Reddy's Laboratories Recent Developments
  109. 7.19 Cipla
  110. 7.19.1 Cipla Company Information
  111. 7.19.2 Cipla Business Overview
  112. 7.19.3 Cipla Allylamines Antifungal Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Cipla Allylamines Antifungal Drugs Product Portfolio
  114. 7.19.5 Cipla Recent Developments
  115. 7.20 Abbott Laboratories
  116. 7.20.1 Abbott Laboratories Company Information
  117. 7.20.2 Abbott Laboratories Business Overview
  118. 7.20.3 Abbott Laboratories Allylamines Antifungal Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Abbott Laboratories Allylamines Antifungal Drugs Product Portfolio
  120. 7.20.5 Abbott Laboratories Recent Developments
8 North America
  1. 8.1 North America Allylamines Antifungal Drugs Market Size by Type
  2. 8.1.1 North America Allylamines Antifungal Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Allylamines Antifungal Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Allylamines Antifungal Drugs Price by Type (2021-2032)
  5. 8.2 North America Allylamines Antifungal Drugs Market Size by Application
  6. 8.2.1 North America Allylamines Antifungal Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Allylamines Antifungal Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Allylamines Antifungal Drugs Price by Application (2021-2032)
  9. 8.3 North America Allylamines Antifungal Drugs Market Size by Country
  10. 8.3.1 North America Allylamines Antifungal Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Allylamines Antifungal Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Allylamines Antifungal Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Allylamines Antifungal Drugs Market Size by Type
  2. 9.1.1 Europe Allylamines Antifungal Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Allylamines Antifungal Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Allylamines Antifungal Drugs Price by Type (2021-2032)
  5. 9.2 Europe Allylamines Antifungal Drugs Market Size by Application
  6. 9.2.1 Europe Allylamines Antifungal Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Allylamines Antifungal Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Allylamines Antifungal Drugs Price by Application (2021-2032)
  9. 9.3 Europe Allylamines Antifungal Drugs Market Size by Country
  10. 9.3.1 Europe Allylamines Antifungal Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Allylamines Antifungal Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Allylamines Antifungal Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Allylamines Antifungal Drugs Market Size by Type
  2. 10.1.1 China Allylamines Antifungal Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Allylamines Antifungal Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Allylamines Antifungal Drugs Price by Type (2021-2032)
  5. 10.2 China Allylamines Antifungal Drugs Market Size by Application
  6. 10.2.1 China Allylamines Antifungal Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Allylamines Antifungal Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Allylamines Antifungal Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Allylamines Antifungal Drugs Market Size by Type
  2. 11.1.1 Asia Allylamines Antifungal Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Allylamines Antifungal Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Allylamines Antifungal Drugs Price by Type (2021-2032)
  5. 11.2 Asia Allylamines Antifungal Drugs Market Size by Application
  6. 11.2.1 Asia Allylamines Antifungal Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Allylamines Antifungal Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Allylamines Antifungal Drugs Price by Application (2021-2032)
  9. 11.3 Asia Allylamines Antifungal Drugs Market Size by Country
  10. 11.3.1 Asia Allylamines Antifungal Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Allylamines Antifungal Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Allylamines Antifungal Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Allylamines Antifungal Drugs Market Size by Type
  2. 12.1.1 SAMEA Allylamines Antifungal Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Allylamines Antifungal Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Allylamines Antifungal Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Allylamines Antifungal Drugs Market Size by Application
  6. 12.2.1 SAMEA Allylamines Antifungal Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Allylamines Antifungal Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Allylamines Antifungal Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Allylamines Antifungal Drugs Market Size by Country
  10. 12.3.1 SAMEA Allylamines Antifungal Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Allylamines Antifungal Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Allylamines Antifungal Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Allylamines Antifungal Drugs Value Chain Analysis
  2. 13.1.1 Allylamines Antifungal Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Allylamines Antifungal Drugs Production Mode & Process
  6. 13.2 Allylamines Antifungal Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Allylamines Antifungal Drugs Distributors
  9. 13.2.3 Allylamines Antifungal Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst